深圳生命健康产业发展规划(2013-2020年)将重点发展生命信息、高端医疗等六大领域

2013-12-22 MedSci MedSci原创

生命健康产业是我市确定要培育发展的未来产业之一。昨天下午,生命健康产业发展规划(2013-2020年)获市政府常务会议原则通过,该规划提出,我市发展生命健康产业将以生命信息、高端医疗、健康管理、照护康复、养生保健、健身休闲等六大领域为重点。 深圳2012年生命健康产业规模约250亿元 根据有关统计,美国、法国和德国的健康消费支出占GDP的比重超过10%。与发达国家相比,我国健康产业规模

生命健康产业是我市确定要培育发展的未来产业之一。昨天下午,生命健康产业发展规划(2013-2020年)获市政府常务会议原则通过,该规划提出,我市发展生命健康产业将以生命信息、高端医疗、健康管理、照护康复、养生保健、健身休闲等六大领域为重点。

深圳2012年生命健康产业规模约250亿元

根据有关统计,美国、法国和德国的健康消费支出占GDP的比重超过10%。与发达国家相比,我国健康产业规模仍然较小,占GDP的比重不足5%,生命健康产业在我国具有广阔的发展前景。

规划从产业支撑条件、优势行业现状、自主创新能力、产业发展环境等方面,分析了我市发展生命健康产业的良好基础。

统计数字显示,2012年我市生命健康产业规模约250亿元,生命信息、高端医疗等行业具有全球竞争力,在全国处于引领地位。

其中,新一代测序能力与超大规模生物信息计算与分析能力位居世界第一,无创产前基因检测、疾病筛查等示范应用有序推进,华大基因已成为世界最大的基因组研发与科技服务机构。

2015年成为我国生命健康产业发展领先城市

规划提出了我市发展生命健康产业的基本原则,即立足民生,着眼长远;创新引领,突出特色;开放合作,广聚资源;政府引导,市场运作;优化布局,协调发展。

根据规划提出的发展目标,到2015年,我市生命健康产业规模预计将超过500亿元,年销售收入超10亿元的龙头企业3-5家,超亿元企业50家,成为我国生命健康产业发展的领先城市。

到2020年,我市生命健康产业体系将基本完善,成为全球重要的生命健康产业基地,国际领先的生命信息和高端医疗服务中心,国内知名的健康管理和养生休闲服务中心。

围绕重点领域实施13项行动计划

围绕生命信息等重点发展领域,规划制定了13项行动计划。每项行动计划明确了发展目标、支撑体系建设、提升创新能力、推进试点示范等内容。

其中,生命信息领域重点发展生命信息服务和制造;高端医疗领域重点发展个体化治疗、第三方医学检测等高端技术、新型服务、新兴业态;健康管理领域重点发展个性化健康管理和数字化健康管理。

此外,照护康复领域将重点发展养老服务、专业母婴护理、康复服务及相关设备制造业;养生保健领域重点发展中医养生、医疗美容、新型保健品等服务和产品制造;健身休闲领域重点发展体育运动设备、健身器械研发制造和健身休闲服务。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2019146, encodeId=36eb20191468b, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Thu May 15 17:23:00 CST 2014, time=2014-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690228, encodeId=3c0c1690228a9, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Fri Oct 24 00:23:00 CST 2014, time=2014-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672408, encodeId=8c5816e24080e, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Oct 23 15:23:00 CST 2014, time=2014-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741052, encodeId=87971e4105215, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Thu Apr 03 06:23:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746283, encodeId=6bec1e46283a1, content=<a href='/topic/show?id=a680102546cd' target=_blank style='color:#2F92EE;'>#高端医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102546, encryptionId=a680102546cd, topicName=高端医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c135693899, createdName=zhmscau, createdTime=Fri Aug 22 11:23:00 CST 2014, time=2014-08-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2019146, encodeId=36eb20191468b, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Thu May 15 17:23:00 CST 2014, time=2014-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690228, encodeId=3c0c1690228a9, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Fri Oct 24 00:23:00 CST 2014, time=2014-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672408, encodeId=8c5816e24080e, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Oct 23 15:23:00 CST 2014, time=2014-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741052, encodeId=87971e4105215, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Thu Apr 03 06:23:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746283, encodeId=6bec1e46283a1, content=<a href='/topic/show?id=a680102546cd' target=_blank style='color:#2F92EE;'>#高端医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102546, encryptionId=a680102546cd, topicName=高端医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c135693899, createdName=zhmscau, createdTime=Fri Aug 22 11:23:00 CST 2014, time=2014-08-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2019146, encodeId=36eb20191468b, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Thu May 15 17:23:00 CST 2014, time=2014-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690228, encodeId=3c0c1690228a9, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Fri Oct 24 00:23:00 CST 2014, time=2014-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672408, encodeId=8c5816e24080e, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Oct 23 15:23:00 CST 2014, time=2014-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741052, encodeId=87971e4105215, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Thu Apr 03 06:23:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746283, encodeId=6bec1e46283a1, content=<a href='/topic/show?id=a680102546cd' target=_blank style='color:#2F92EE;'>#高端医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102546, encryptionId=a680102546cd, topicName=高端医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c135693899, createdName=zhmscau, createdTime=Fri Aug 22 11:23:00 CST 2014, time=2014-08-22, status=1, ipAttribution=)]
    2014-10-23 respect
  4. [GetPortalCommentsPageByObjectIdResponse(id=2019146, encodeId=36eb20191468b, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Thu May 15 17:23:00 CST 2014, time=2014-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690228, encodeId=3c0c1690228a9, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Fri Oct 24 00:23:00 CST 2014, time=2014-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672408, encodeId=8c5816e24080e, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Oct 23 15:23:00 CST 2014, time=2014-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741052, encodeId=87971e4105215, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Thu Apr 03 06:23:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746283, encodeId=6bec1e46283a1, content=<a href='/topic/show?id=a680102546cd' target=_blank style='color:#2F92EE;'>#高端医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102546, encryptionId=a680102546cd, topicName=高端医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c135693899, createdName=zhmscau, createdTime=Fri Aug 22 11:23:00 CST 2014, time=2014-08-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2019146, encodeId=36eb20191468b, content=<a href='/topic/show?id=359f68922cd' target=_blank style='color:#2F92EE;'>#生命健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68922, encryptionId=359f68922cd, topicName=生命健康)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0361487, createdName=花花1366, createdTime=Thu May 15 17:23:00 CST 2014, time=2014-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690228, encodeId=3c0c1690228a9, content=<a href='/topic/show?id=805b244019d' target=_blank style='color:#2F92EE;'>#产业发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24401, encryptionId=805b244019d, topicName=产业发展)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=208e29003854, createdName=12498fa0m20暂无昵称, createdTime=Fri Oct 24 00:23:00 CST 2014, time=2014-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672408, encodeId=8c5816e24080e, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu Oct 23 15:23:00 CST 2014, time=2014-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741052, encodeId=87971e4105215, content=<a href='/topic/show?id=89f12e726ee' target=_blank style='color:#2F92EE;'>#健康产业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27726, encryptionId=89f12e726ee, topicName=健康产业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f0d34859827, createdName=12498e0fm89暂无昵称, createdTime=Thu Apr 03 06:23:00 CST 2014, time=2014-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1746283, encodeId=6bec1e46283a1, content=<a href='/topic/show?id=a680102546cd' target=_blank style='color:#2F92EE;'>#高端医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102546, encryptionId=a680102546cd, topicName=高端医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9c135693899, createdName=zhmscau, createdTime=Fri Aug 22 11:23:00 CST 2014, time=2014-08-22, status=1, ipAttribution=)]